Molecular docking and dynamics simulation of main protease of SARS-CoV-2 with naproxen derivative

被引:2
|
作者
Hussein, Rageh K. [1 ]
Marashdeh, Mohammad [1 ]
El-Khayatt, Ahmed M. [1 ]
机构
[1] Imam Mohammad Ibn Saud Islamic Univ IMSIU, Coll Sci, Dept Phys, Riyadh, Saudi Arabia
关键词
Naproxen derivative; SARS-CoV-2; drug-likeness and ADMET properties; Molecular docking; Molecular dynamics;
D O I
10.6026/97320630019358
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Naproxen is a well-known anti-inflammatory drug that is frequently used to relieve inflammation, stiffness, and swelling. Naproxen has previously demonstrated antiviral activity, particularly against the influenza-A virus. There have been previous studies regarding naproxen effect on SARS-CoV-2 infection. Therefore, it is of interest to document the molecular docking and dynamics simulation data of main protease of SARS-CoV-2 with naproxen derivative for further consideration.
引用
收藏
页码:358 / 361
页数:4
相关论文
共 50 条
  • [1] Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
    Cardoso, Wesley B.
    Mendanha, Sebastiao A.
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2021, 1225
  • [2] Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
    Omer, Samia E.
    Ibrahim, Tawasol M.
    Krar, Omer A.
    Ali, Amna M.
    Makki, Alaa A.
    Ibraheem, Walaa
    Alzain, Abdulrahim A.
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 29
  • [3] Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
    Mahmud, Shafi
    Biswas, Suvro
    Paul, Gobindo Kumar
    Mita, Mohasana Akter
    Afrose, Shamima
    Hasan, Md Robiul
    Shimu, Mst Sharmin Sultana
    Uddin, Mohammad Abu Raihan
    Uddin, Md Salah
    Zaman, Shahriar
    Kibria, K. M. Kaderi
    Khan, Md Arif
    Bin Emran, Talha
    Abu Saleh, Md
    [J]. ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (09)
  • [4] SARS-CoV-2 Main Protease: A Molecular Dynamics Study
    Suarez, Dimas
    Diaz, Natalia
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5815 - 5831
  • [5] Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (MPro)
    El Khatabi, Khalil
    Aanouz, Ilham
    Alaqarbeh, Marwa
    Ajana, Mohammed Aziz
    Lakhifi, Tahar
    Bouachrine, Mohammed
    [J]. BIOIMPACTS, 2022, 12 (02) : 107 - 113
  • [6] Exploring the inhibition mechanism of SARS-CoV-2 main protease by ebselen: A molecular docking, molecular dynamics simulation and DFT approach
    You, Wanli
    Chen, Yuandao
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2023, 44 (26) : 2086 - 2095
  • [7] Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation
    Azam, Faizul
    Eid, Eltayeb E. M.
    Almutairi, Abdulkarim
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2021, 1246
  • [8] Insilico assessment of hesperidin on SARS-CoV-2 main protease and RNA polymerase: Molecular docking and dynamics simulation approach
    Molaakbari, Elaheh
    Aallae, Mohammad Reza
    Golestanifar, Fereshteh
    Garakani-Nejad, Zahra
    Khosravi, Ahmad
    Rezapour, Mohsen
    Malekshah, Rahime Eshaghi
    Ghomi, Mahsa
    Ren, Guogang
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
  • [9] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
    Ahmad, Fawad
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad Ur
    Khattak, Saeed Ullah
    Butt, Sadia
    Mushtaq, Maryam
    [J]. SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484
  • [10] Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2
    Mahmud, Shafi
    Uddin, Mohammad Abu Raihan
    Zaman, Meemtaheena
    Sujon, Khaled Mahmud
    Rahman, Md Ekhtiar
    Shehab, Mobasshir Noor
    Islam, Ariful
    Alom, Md Wasim
    Amin, Al
    Akash, Al Shahriar
    Abu Saleh, Md
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16): : 6281 - 6289